News | August 11, 2021
Lupin posts net profit of Rs 542.46 cr. in Q1FY22
The profits were bolstered by the Boehringer Ingelheim MEK program income
The profits were bolstered by the Boehringer Ingelheim MEK program income
Formulation business grew by 15 per cent in the quarter
India business contributes to a stellar performance
The company has been consistently reducing debt
FreeStyle Libre 2 iOS app is the only sensor-based glucose monitoring app that allows users to check their glucose with a compatible iPhone every minute with optional real-time glucose alarms
This deal makes Meddo, one of the largest health-tech players in India
The govt has rolled out three schemes for promoting the manufacture of API
India business is growing as per projections; whereas US business will bounce back soon.
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
Price band in the range of Rs 933 to Rs 954
Subscribe To Our Newsletter & Stay Updated
